Dr. Fauci at IAS 2015: Comprehensive global prevention can end HIV/AIDS pandemic
2015-07-21
(Press-News.org) Although much progress has been made in combating the global HIV/AIDS pandemic, to halt new infections and end the pandemic, a combination of non-vaccine and vaccine prevention modalities will be needed. Even with these tools, significant implementation gaps must be closed, including the targeted deployment of proven prevention methods to the populations that need them most, says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Fauci addressed a special session at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada.
Dr. Fauci will describe how proven medical interventions have been successfully applied to a range of prevention strategies, including antiretroviral therapy (ART), medical male circumcision, daily pre-exposure prophylaxis (PrEP) and treatments that prevent mother-to-child HIV transmission. He also will review how treatment of HIV-infected people early in the course of their infection can dramatically reduce the risk of transmitting HIV to an uninfected sexual partner, while simultaneously protecting the health of the infected individual. Although these interventions can dramatically reduce the rate of HIV infection, some individuals find it difficult to adhere to ART, which presents obstacles to optimal implementation of these programs.
Several approaches towards the development of an HIV vaccine are currently being pursued, Dr. Fauci notes. The Pox-Protein Public-Private Partnership (P5), of which NIAID is a member, is exploring strategies in South African trials to amplify the encouraging results from RV 144, an HIV vaccine clinical trial in Thailand that resulted in the first modest signal of efficacy. Scientists also are investigating the potential use of broadly neutralizing antibodies directed against HIV which are elicited in natural infection in some HIV-infected individuals. These antibodies already are being tested for use via passive transfer in treatment and prevention of transmission. Scientists in pursuit of an HIV vaccine are building on this work, designing techniques to elicit these antibodies through sequential stimulation of the immune system with specifically designed immunogens.
Better application of proven prevention technologies can help drive down the global incidence of HIV. If these methods can be combined with an effective vaccine, the end of the HIV/AIDS pandemic could be within reach, according to Dr. Fauci. However, to realize that potential, substantial implementation gaps will need to be closed. For example, evidence shows that HIV risk is not uniformly distributed; certain high-transmission areas have disproportionately elevated rates of incidence as compared to neighboring districts. Dr. Fauci will discuss that by focusing on these areas, understanding the drivers of HIV risk and deploying prevention technologies, HIV transmission could be decreased dramatically, finally halting the spread of HIV.
INFORMATION:
PRESENTATION:
Dr. Fauci spoke in a special session of the 8th International AIDS Society Conference on HIV Pathogenesis in Vancouver, Canada, delivering remarks on "Progress and Challenges in HIV Prevention: Vaccine and Non-Vaccine Approaches." A videocast of his lecture will be posted on the IAS website, http://IAS2015.org/.
A Fauci. Progress and challenges in HIV prevention: vaccine and non-vaccine approaches. Program number MOSS01.
WHO:
NIAID Director Anthony S. Fauci, M.D., is available for comment.
CONTACT:
To schedule interviews, please contact Anne Rancourt, (301) 402-1663, anne.rancourt@nih.gov.
NIAID conducts and supports research--at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health® END
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-21
Irvine, Calif., July 21, 2015 - The 11 percent decrease in climate change-causing carbon dioxide emissions in the U.S. between 2007 and 2013 was caused by the global financial recession - not the reduced use of coal, research from the University of California Irvine, the University of Maryland, and the International Institute for Applied Systems Analysis shows.
Experts have assumed that the drop in emissions reflected a shift toward natural gas, which produces roughly half as much carbon dioxide per unit of energy as coal and was made cheap by the hydraulic fracturing ...
2015-07-21
Only one in three older Americans have their diabetes under control as measured by guidelines set by the American Diabetes Association, new Johns Hopkins Bloomberg School of Public Health research suggests.
Some argue that ADA guidelines may be too stringent for some older adults. But even using less stringent measures, the researchers found, there are still many older Americans whose diabetes is not well managed, a condition that can lead to multiple long-term health problems ranging from kidney disease to blindness.
In a report published in the July issue of Diabetes ...
2015-07-21
Most of us think of infants as tiny beings whose main business is to sleep, suck and cry, without much awareness of what is happening around them. It may come as somewhat of a surprise, then, to know that newborn brains are full of feverish activity and that they are already gathering and processing important information from the world around them. At just two days after birth, babies are already able to process language using processes similar to those of adults. SISSA researchers have demonstrated that they are sensitive to the most important parts of words, the edges, ...
2015-07-21
One of the most basic yet important surgical skills to keep a patient alive and intact may be closing wounds. It seems that doctors will now get the job done with more ease thanks to new, nontoxic surgical glue that instantly seals a bleeding wound and helps it heal without a scar or inflammation.
Inspired by nature's wonders, Korean scientists at Pohang University of Science and Technology (POSTECH) have developed a light-activated, mussel protein-based bioadhesive (LAMBA) that works on the same principles as mussels attaching to underwater surfaces and insects maintaining ...
2015-07-21
PROVIDENCE, R.I. [Brown University] -- When the HOPE VI community revitalization project in the disadvantaged Birmingham, Ala., neighborhood of Ensley reached the phase of building walking and biking paths, green spaces, and improved lighting in 2010, two things happened, according to a new study: First, residents developed specific expectations that leisure exercise would become more plausible, and then they followed through and got out there.
Before the neighborhood's revitalization, launched in 2006 with funding from the federal program Housing Opportunities for People ...
2015-07-21
A vaccine that protects against a wide variety of influenza viruses (a so-called universal flu vaccine) is a critical public health goal given the significant rates of illness and death caused by seasonal influenza and the potentially devastating effects of a pandemic influenza strain. Now, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have devised a way to induce protective immunity in mice against a wide array of influenza viruses.
Instead of trying to predict which influenza virus strains ...
2015-07-21
This news release is available in German. In 2003, Europe experienced a record-breaking summer, and many people feel that this summer is headed the same way. In the midst of this heatwave, the scientific journal Nature Geoscience has published a study that can help us to understand such extreme weather conditions. For around two years, an ETH research team has analysed climate data from all over the world in a bid to explain the driving force behind stable high-pressure systems. It has long been known that extremely stable high-pressure systems in the upper troposphere, ...
2015-07-21
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
The ability to sense environmental nutrient availability and act accordingly is a critical process for all organisms. Changing behaviour in response to nutrients can occur at many levels: the activity of proteins can be varied or new genes can be activated to produce a different set of proteins. Research published in the latest issue of ...
2015-07-21
A majority of men who have sex with men (MSM) and transgender women (TGW) at high risk for HIV infection took anti-HIV medication for pre-exposure prophylaxis (PrEP), most of the time, in a multi-site U.S. study examining use of this HIV prevention strategy outside of a clinical trial. The study, called the PrEP Demo Project, was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The study findings will be presented by Albert Liu, M.D., of the San Francisco Department of Public Health, at the 8th International ...
2015-07-21
Children born with ADNP-related autism syndrome suffer from a heart-breaking combination of ambiguous developmental problems injurious to both their physical health and cognitive functioning. For parents, the mystery surrounding their infants' suffering can be even more agonizing than the syndrome itself, which has no known cure.
Recent research from Tel Aviv University and the University of Antwerp is easing some of that agony. Activity-dependent neuroprotective protein (ADNP), discovered by TAU's Prof. Illana Gozes 15 years ago, has now been shown by Prof. Frank Kooy ...
LAST 30 PRESS RELEASES:
[Press-News.org] Dr. Fauci at IAS 2015: Comprehensive global prevention can end HIV/AIDS pandemic
